Core Insights - Philip Morris International Inc. (PMI) has announced an expanded partnership with Scuderia Ferrari HP and Ferrari Challenge Trofeo Pirelli for the 2026 season and beyond, featuring the ZYN brand of nicotine pouches on Ferrari's Formula 1 liveries [1] - The partnership aims to innovate and challenge the status quo in the nicotine market, with a focus on smoke-free alternatives to cigarettes [1] - ZYN branding will debut on the Scuderia Ferrari HP car during the Abu Dhabi Grand Prix on December 7, 2025 [1] Company Overview - PMI is a leading international consumer goods company focused on delivering a smoke-free future and evolving its product portfolio beyond tobacco and nicotine [1] - The company's product portfolio includes cigarettes and smoke-free products such as heat-not-burn, nicotine pouches, and e-vapor products, available in over 100 markets [1] - As of June 30, 2025, PMI estimates that over 41 million legal-age consumers globally use its smoke-free products, which accounted for 41% of the company's total net revenues in the first nine months of 2025 [1] Investment in Innovation - Since 2008, PMI has invested over $14 billion in the development and commercialization of innovative smoke-free products aimed at reducing cigarette consumption [1] - The company has established world-class scientific assessment capabilities in areas such as toxicology, clinical research, and post-market studies [1] - PMI has received FDA authorizations for various products, including ZYN nicotine pouches and IQOS devices, marking significant milestones in the industry [1]

Core Insights - The survey indicates strong global support for smoke-free alternatives to cigarettes, with 78% of respondents agreeing that adult smokers should have access to better options [2][3] - There is significant concern (76%) that public health decisions are influenced more by ideology than by scientific evidence [3][6] - Countries that adopt smoke-free products have experienced declines in cigarette sales and smoking rates, highlighting the demand for evidence-based policies [4] Group 1: Public Support for Smoke-Free Alternatives - 80% of adults believe that smokers should have access to smoke-free options [1] - 74% of respondents think that encouraging smokers to switch to these products can improve public health [2] - 78% of respondents want their governments to consider scientific evidence regarding smoke-free alternatives before imposing restrictions [3] Group 2: Concerns Over Public Health Policies - 76% of respondents are concerned that decisions are made based on ideology rather than science [3][6] - 58% agree that it is wrong for governments to ban less harmful alternatives while allowing cigarette sales [6] - 61% believe it is a public health failure that 29% of the global adult population lives in countries where smoke-free alternatives are banned [6] Group 3: Market Access and Regulatory Environment - Over 190 million smokers in more than 20 countries lack legal access to smoke-free products, despite the availability of harmful cigarettes [5] - 82% of legal-age smokers in countries with bans on smoke-free products want the opportunity to purchase them legally [6] - The survey highlights a strong desire for governments to adopt policies that align with scientific findings, particularly in countries with existing bans [3][6] Group 4: Company Position and Investment - Philip Morris International has invested over $14 billion since 2008 in developing smoke-free products, aiming to end cigarette sales [8] - As of June 30, 2025, smoke-free products accounted for 41% of PMI's total net revenues [8] - PMI's smoke-free products are available in 97 markets, with over 41 million legal-age consumers using them [8]